CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
High ImpactOriginal article

Tenax plummets on phase 3 failure of pulmonary hypertension drug

Phase 3negativeNegative
AI Analysis

Summary

Tenax's Phase 3 trial for a pulmonary hypertension drug failed, causing the company's stock to plummet significantly.

Clinical Trial Data

Phase

3

Primary Endpoint

Not Met

Importance:8/10
Sentiment:
-0.95
Phase 3 failurepulmonary hypertensionclinical trialnegative catalyst

Read the original article

Published by Seeking Alpha Healthcare on August 10, 2026 2:26 PM

Read Original